Tempest Therapeutics, Inc. · NASDAQ:TPST
Angel Matthew bought 231,482 Tempest Therapeutics, Inc. shares (Form 4)
Traded Mar 24, 2026 · Filed Jun 23, 2026
On Mar 24, 2026, Angel Matthew (Director, CEO and President, 10% owner) bought 231,482 Tempest Therapeutics, Inc. shares at US$2.16 for US$500K, leaving 231,482 shares. Filed Jun 23, 2026 (Form 4).
- Bought
- 231,482 shares
- Price
- US$2.16
- Value
- US$500K
- Holding after
- 231,482 shares (held indirectly)
- Trading plan
- No
- Role
- Director, CEO and President, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 24, 2026 | Common Stock | Buy | 231,482 | US$2.16 | 231,482 | Indirect |